Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer

Name: Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
License: Public Domain

Celgene

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma small

carcinoma, non-small-cell lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256863
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.